# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-21-018473
Filing Date
2021-03-30
Accepted
2021-03-30 07:56:25
Documents
96
Period of Report
2020-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ANNUAL REPORT | f10k2020_immucellcorp.htm | 10-K | 813001
2 | DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE SECURITIES EXCHANGE | f10k2020ex4-2_immucell.htm | EX-4.2 | 28064
3 | AMENDED AND RESTATED INCENTIVE COMPENSATION AGREEMENT BETWEEN THE COMPANY AND BO | f10k2020ex10-12_immucell.htm | EX-10.12 | 12716
4 | CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | f10k2020ex23-1_immucell.htm | EX-23.1 | 2486
5 | CERTIFICATION | f10k2020ex31_immucell.htm | EX-31 | 8978
6 | CERTIFICATION | f10k2020ex32_immucell.htm | EX-32 | 5580
| Complete submission text file | 0001213900-21-018473.txt |  | 5152482

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL INSTANCE FILE | iccc-20201231.xml | EX-101.INS | 843586
8 | XBRL SCHEMA FILE | iccc-20201231.xsd | EX-101.SCH | 66476
9 | XBRL CALCULATION FILE | iccc-20201231_cal.xml | EX-101.CAL | 77070
10 | XBRL DEFINITION FILE | iccc-20201231_def.xml | EX-101.DEF | 177298
11 | XBRL LABEL FILE | iccc-20201231_lab.xml | EX-101.LAB | 470954
12 | XBRL PRESENTATION FILE | iccc-20201231_pre.xml | EX-101.PRE | 348796

Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12934 | Film No.: 21783666
SIC: 2835 In Vitro & In Vivo Diagnostic Substances